Sophiris Bio Inc Net debt/EBITDA
Was ist das Net debt/EBITDA von Sophiris Bio Inc?
Net debt/EBITDA von Sophiris Bio Inc ist 0.48
Was ist die Definition von Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Sophiris Bio Inc
Unternehmen mit net debt/ebitda ähnlich Sophiris Bio Inc
- Charles Schwab hat Net debt/EBITDA von 0.48
- Chargepoint hat Net debt/EBITDA von 0.48
- Neles Oyj hat Net debt/EBITDA von 0.48
- Blueberries Medical hat Net debt/EBITDA von 0.48
- Sunrise Resources plc hat Net debt/EBITDA von 0.48
- Boardwalktech Software hat Net debt/EBITDA von 0.48
- Sophiris Bio Inc hat Net debt/EBITDA von 0.48
- GOLO Mobile hat Net debt/EBITDA von 0.48
- Aimia hat Net debt/EBITDA von 0.48
- China Health hat Net debt/EBITDA von 0.49
- Wai Chi hat Net debt/EBITDA von 0.49
- Universal Health International hat Net debt/EBITDA von 0.49
- WABCO hat Net debt/EBITDA von 0.49